Advertisement
Advertisement

Stephanie Sutton

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Articles

Advertisement

News: FDA's Social Media Insight

February 01, 2012

How can pharma make use of social media opportunities without running afoul of regulators?

Personalizing for Better Products

January 27, 2012

Pharmaceutical drug development is becoming more and more expensive, with a high incidence of products failing late-stage trials. Governments and healthcare payers are demanding medicines that offer a balance of benefit and cost.

Call for Funding to End Animal Experiments

January 26, 2012

As the EU debates how best to spend billions of euros worth of research funding, the Humane Society International/Europe has issued a call to develop in vitro and computational techniques that can replace the use of animals in medical experiments.

European Outsourcing Revenue to Grow by 50%

January 26, 2012

According to a report from Frost & Sullivan, the European pharmaceutical contract manufacturing market could earn revenues of up to $20.75 billion in 2018, almost double that of 2011's revenue when the market earned $10.02 billion. Over the same period, the European market for biotechnology outsourcing is forecast to grow from $1.21 billion to $2.67 billion.

Takeda to Axe 2100 Jobs in Europe

January 20, 2012

Takeda has announced "strategic measures to achieve efficiencies for long-term growth", which includes cutting close to 3000 jobs, 2100 of which will come from Europe.

Advertisement

Celebrity Chef and Pharma Unite

January 20, 2012

Earlier this week, Novo Nordisk launched a diabetes initiative in the US that stars the celebrity chef Paula Deen. Usually, it’s the pharma company that gets the sharp end of the stick when it comes to criticism but this time the negative attention has fallen on Deen, with Norvo Nordisk barely getting a mention in many news sources.

Advertisement
Advertisement
Advertisement
x